This is the authors' abstract. We don't add key points for this paper.
It is not uncommon to encounter outpatients in the hepatology department with harmful alcohol habits. When treating such chronic liver disease (CLD) patients, an adequate intervention method for harm reduction of alcohol use, such as brief intervention (BI) or BI and nalmefene, should be considered. This study aimed to elucidate the clinical effectiveness of BI for CLD patients affected by harmful alcohol use.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: